SCHEMBL163416

SCHEMBL163416

C=C(C(N)=O)C1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
NOS2 P35228 2/20 0.40
EPHX1 P07099 3/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MGLL Q99685 1/20 0.37
HSD11B1 P28845 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
CYP2D6 P10635 1/20 0.35
RECQL P46063 1/20 0.34
ALOX5 P09917 1/20 0.34
SRD5A2 P31213 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
HSD11B2 P80365 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3114031 1.00 CES2 (0.48) CES2CES1HDAC8HDAC6NOS2
SCHEMBL4079495 1.00 CES2 (0.48) CES2CES1HDAC8HDAC6NOS2
SCHEMBL532571 0.97 CES2 (0.43) CES2CES1HDAC8HDAC6NOS2
SCHEMBL4743865 0.92
SCHEMBL730807 0.87 TDP1 (0.38) NOS2KDM4EMAPTKMT2AATM
SCHEMBL543402 0.87
SCHEMBL761934 0.79 CES2 (0.52) CES2CES1HDAC8HDAC6EPHX1
SCHEMBL6360577 0.78 EPHX2 (0.34) NOS2TDP1
SCHEMBL20272049 0.78 TDP1 (0.32) NOS2TDP1
Propane SCHEMBL28407353 0.78 SMN1; SMN2 (0.38) NOS2KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 933 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260040695-A1 A METHOD TO GENERATE CONDUCTIVE POLYMER NEWSOUTH INNOVATIONS PTY LTD (AU) 2026-02-05 US claimed
EP-4562077-A1 A METHOD TO GENERATE CONDUCTIVE POLYMER NewSouth Innovations Pty Limited (AU) 2025-06-04 EP claimed
WO-2024020649-A1 A METHOD TO GENERATE CONDUCTIVE POLYMER NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2024-02-01 WO claimed
WO-2022261721-A1 HEALABLE AND REPROCESSABLE COMPOSITIONS DEAKIN UNIVERSITY (AU) 2022-12-22 WO claimed
WO-2022115787-A1 BLOCK COPOLYMERS DERVIED FROM SHORT AND LONG ALKYL CHAIN ACRYLATES OR ACRYLAMIDES AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2022-06-02 WO claimed
CN-110291136-A Water-swellable polymer particles 巴斯夫欧洲公司 2019-09-27 CN claimed
CN-110234405-A Cosmetic composition comprising cationic copolymer 科莱恩国际有限公司 2019-09-13 CN claimed
CN-110177816-A Copolymers and their use in detergent compositions 科莱恩国际有限公司 2019-08-27 CN claimed
CN-110088259-A Detergent compositions containing copolymers 科莱恩国际有限公司 2019-08-02 CN claimed
CN-110023472-A COPOLYMERS AND THEIR USE IN DETERGENT COMPOSITIONS 科莱恩国际有限公司 2019-07-16 CN claimed
EP-1776176-A1 COMPOSITE MATERIAL COMPRISING A NON-CROSSLINKED GEL POLYMER McMaster University (CA) 2007-04-25 EP claimed
US-20060074142-A1 Aqueous inks containing colored polymers XEROX CORPORATION 2006-04-06 US claimed
WO-2006015495-A1 COMPOSITE MATERIAL COMPRISING A NON-CROSSLINKED GEL POLYMER MCMASTER UNIVERSITY (CA) 2006-02-16 WO claimed
EP-1530600-A1 BIO-SYNTHETIC MATRIX AND USES THEREOF Ottawa Health Research Institute (CA) 2005-05-18 EP claimed
WO-2004014969-A1 BIO-SYNTHETIC MATRIX AND USES THEREOF OTTAWA HEALTH RESEARCH INSTITUTE (CA) 2004-02-19 WO claimed
WO-2004015090-A2 INNERVATED ARTIFICIAL TISSUES AND USES THEREOF OTTAWA HEALTH RESEARCH INSTITUTE (CA) 2004-02-19 WO claimed
EP-0774096-A4 A METHOD FOR INHIBITING HYDRATE FORMATION EXXON PRODUCTION RESEARCH CO (US) 1999-01-13 EP claimed
EP-0774096-A1 A METHOD FOR INHIBITING HYDRATE FORMATION EXXON PRODUCTION RESEARCH COMPANY (US) 1997-05-21 EP claimed
WO-1996008672-A1 A METHOD FOR INHIBITING HYDRATE FORMATION EXXON PRODUCTION RESEARCH COMPANY (US) 1996-03-21 WO claimed
US-5352365-A Process for removing scale, and reducing scale formation in sewage treatment plants FULLER RICHARD L (US) 1994-10-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260040695-A1 A METHOD TO GENERATE CONDUCTIVE POLYMER PIEZO1, LCP1, MTCL3 CES2 4022/4885CES1 4759/4885HDAC8 4438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.